Treatment of sporadic hemiplegic migraine with calcium-channel blocker verapamil
Authors:
- 14 January 2003
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 60 (1) , 120-121
Abstract
Gene mutations within the P/Q type neuronal calcium channel in familial hemiplegic migraine (FHM) suggest a therapeutic role for calcium-channel blockade. The authors have previously reported abortive therapy of FHM with IV verapamil. Here the authors describe four cases of sporadic hemiplegic migraine (SHM) responsive to verapamil, administered either orally or IV. The findings indicate that verapamil is effective therapy for both SHM and FHM.Keywords
This publication has 10 references indexed in Scilit:
- Familial hemiplegic migraine and its abortive therapy with intravenous verapamilNeurology, 2001
- The Clinical Spectrum of Familial Hemiplegic Migraine Associated with Mutations in a Neuronal Calcium ChannelNew England Journal of Medicine, 2001
- CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophyNeurology, 2000
- Hemiplegic migraine induced by exertion.Archives of Neurology, 2000
- Neonatal Endocrinology of Abnormal Male Sexual Differentiation: Molecular AspectsHormone Research in Paediatrics, 2000
- A new CACNA1A gene mutation in acetazolamide-responsive familial hemiplegic migraine and ataxiaNeurology, 1999
- Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene CACNL1A4Cell, 1996
- A Case of Hemiplegic Migraine Treated with FlunarizineHeadache: The Journal of Head and Face Pain, 1987
- Hemiplegic migraine in childhood: Diagnostic and therapeutic aspectsThe Journal of Pediatrics, 1982
- On Recurrent Motor Paralysis in Migraine, with Report of a Family in which Recurrent Hemiplegia Accompanied the AttacksBMJ, 1910